| NCT Number | NCT05856136 |
| Lead Sponsor | Mayo Clinic
Collaborators: National Institute on Drug Abuse (NIDA) |
| Conditions | Respiratory Function Loss, Respiratory Complication |
| Enrollment | 69 participants |
| Start Date | 2023-06-19 |
| Primary Completion | 2025-12-08 (estimated) |
| Study Completion | 2027-01-01 (estimated) |
| Updated on ClinicalTrials.gov | 2026-06-23 |